OAB and Incontinence

>

Latest News

Howard B. Goldman, MD, FACS
The future of OAB treatment: Emerging nerve targets and AI may guide therapy

June 23rd 2025

Howard B. Goldman, MD, FACS, discusses innovations such as tibial nerve stimulation devices, pudendal nerve targeting, and alternative stimulation frequencies.

FDA approves integrated sacral neuromodulation system for urinary urge incontinence
FDA approves integrated sacral neuromodulation system for urinary urge incontinence

June 18th 2025

From prep to follow-up: Key considerations for administering onabotulinumtoxinA
From prep to follow-up: Key considerations for administering onabotulinumtoxinA

June 13th 2025

Addressing an unmet need: CELLEBRATE trial explores cell-based therapy for recurrent SUI
Addressing an unmet need: CELLEBRATE trial explores cell-based therapy for recurrent SUI

May 16th 2025

Published data support safety, efficacy of vaginal insert for SUI
Published data support safety, efficacy of vaginal insert for SUI

May 14th 2025

Video Series
Video Interviews
Podcasts

More News

© 2025 MJH Life Sciences

All rights reserved.